symbol,statement_type,period_end,line_item,value
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.361278
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Normalized EBITDA,2273600000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1065600000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,142800000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,12968400000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,EBITDA,2273600000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,EBIT,2130800000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Interest Income,-419100000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Interest Expense,419100000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Interest Income,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Normalized Income,1065600000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1065600000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Total Expenses,15557700000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Diluted Average Shares,76168692.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Basic Average Shares,76005706.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Diluted EPS,13.99
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Basic EPS,14.02
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,1065600000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,1065600000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Income,1065600000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Minority Interests,-27700000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,1093300000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Income Extraordinary,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,1093300000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Tax Provision,618400000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Pretax Income,1711700000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,463500000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Other Special Charges,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-419100000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,419100000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Operating Income,1616100000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Operating Expense,2589300000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Other Operating Expenses,1504900000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,142700000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Amortization,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,142700000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Selling General And Administration,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Gross Profit,4205400000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Cost Of Revenue,12968400000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Total Revenue,17173800000.0
KOLTEPATIL.NS,income,2025-03-31 00:00:00,Operating Revenue,17173800000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-11221871.031466
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.047834
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Normalized EBITDA,411800000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-234600000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-693500000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,141900000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,10760200000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,EBITDA,411800000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,EBIT,269900000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Interest Income,-978600000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Interest Expense,978600000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Interest Income,76000000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Normalized Income,-235521871.031466
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-693500000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Total Expenses,13345700000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,22200000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Diluted Average Shares,76041667.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Basic Average Shares,76041667.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Diluted EPS,-9.12
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Basic EPS,-9.12
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,-693500000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,-693500000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Income,-693500000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Minority Interests,-18700000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,-674800000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Income Extraordinary,
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,-674800000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Tax Provision,-33900000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Pretax Income,-708700000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,233000000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Special Income Charges,-234600000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Other Special Charges,-3300000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-978600000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,66200000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,978600000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,76000000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Operating Income,369100000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Operating Expense,2585500000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Other Operating Expenses,1471900000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,141900000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Amortization,7000000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,141900000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Selling General And Administration,724000000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,487900000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,General And Administrative Expense,236100000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,22200000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Gross Profit,2954600000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Cost Of Revenue,10760200000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Total Revenue,13714800000.0
KOLTEPATIL.NS,income,2024-03-31 00:00:00,Operating Revenue,13714800000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,32408876.197275
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.325064
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Normalized EBITDA,2082800000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Total Unusual Items,99700000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,99700000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1040600000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,115600000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,10892300000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,EBITDA,2182500000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,EBIT,2066900000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Interest Income,-342400000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Interest Expense,386000000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Interest Income,64300000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Normalized Income,973308876.197275
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1040600000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Total Expenses,13066500000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,18700000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Diluted Average Shares,76000000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Basic Average Shares,76000000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Diluted EPS,13.69
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Basic EPS,13.69
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,1040600000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,1040600000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Income,1040600000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Minority Interests,-93900000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,1134500000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Income Extraordinary,
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,1134500000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Tax Provision,546400000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Pretax Income,1680900000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,122000000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Special Income Charges,1500000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Other Special Charges,-1500000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-342400000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,20700000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,386000000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,64300000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Operating Income,1815200000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Operating Expense,2174200000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Other Operating Expenses,559000000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,115600000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Amortization,7400000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,108200000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Selling General And Administration,626000000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,444900000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,General And Administrative Expense,181100000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,18700000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Gross Profit,3989400000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Cost Of Revenue,10892300000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Total Revenue,14881700000.0
KOLTEPATIL.NS,income,2023-03-31 00:00:00,Operating Revenue,14881700000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-26118189.155477
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.37743
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Normalized EBITDA,2036300000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Total Unusual Items,-69200000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-69200000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,794100000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,103900000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,7722800000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,EBITDA,1967100000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,EBIT,1863200000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Interest Income,-500300000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Interest Expense,500300000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Interest Income,34000000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Normalized Income,837181810.844523
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,794100000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Total Expenses,9416700000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,21400000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Diluted Average Shares,75990431.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Basic Average Shares,75990431.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Diluted EPS,10.45
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Basic EPS,10.45
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,794100000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,794100000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Income,794100000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Minority Interests,-54400000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,848500000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Income Extraordinary,-69200000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,848500000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Tax Provision,514400000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Pretax Income,1362900000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,190200000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Special Income Charges,-69200000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Other Special Charges,-500000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-500300000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,78900000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,500300000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,34000000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Operating Income,1758100000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Operating Expense,1693900000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Other Operating Expenses,884500000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,103900000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Amortization,4800000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,103900000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Selling General And Administration,334100000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,186600000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,General And Administrative Expense,147500000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,21400000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Gross Profit,3452000000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Cost Of Revenue,7722800000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Total Revenue,11174800000.0
KOLTEPATIL.NS,income,2022-03-31 00:00:00,Operating Revenue,11174800000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Total Unusual Items,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,EBITDA,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,EBIT,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Interest Income,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Interest Expense,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Interest Income,34000000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Normalized Income,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Total Expenses,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,10800000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Basic Average Shares,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Diluted EPS,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Basic EPS,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Income,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Minority Interests,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Income Extraordinary,0.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Tax Provision,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Pretax Income,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Special Income Charges,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Other Special Charges,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,56600000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,34000000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Operating Income,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Operating Expense,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Amortization,4700000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Selling General And Administration,316300000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,178300000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,General And Administrative Expense,138000000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,10800000.0
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Gross Profit,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Total Revenue,
KOLTEPATIL.NS,income,2021-03-31 00:00:00,Operating Revenue,
